DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

H.C. Wainwright Maintains Buy on INmune Bio, Lowers Price Target to $8

H.C. Wainwright maintains INmune Bio (NASDAQ:INMB) with a Buy and lowers the price target from $11 to $8.

Benzinga · 03/12/2020 11:42

H.C. Wainwright maintains INmune Bio (NASDAQ:INMB) with a Buy and lowers the price target from $11 to $8.